Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Feb 25, 2021
Indian Giant on the Brink of Meltdown

Indian Giant on the Brink of Meltdown

One of India’s largest financial institutions, Infrastructure Lending and Financial Services, which has helped to fuel the growth of the world’s fastest-growing economy over the past 30 years. But now it threatens to, has now helped to bring India to the brink of crisis.

The company is considered systematically important to the health of the economy, since some of its largest stakeholders include the Central Bank of India, the State Bank of India (NSE: SBIN), the largest mortgage lender in India (NSE: HDBFC), and the largest life insurance company in India, which is state-owned.

IL&FS owns or is affiliated with between 170 and 256 smaller companies, depending on the criteria by which they are categorized, and this has made the current crisis difficult to foresee. Its figurehead resigned for health reasons in July, and it began defaulting on its debts in August, the effects of which have taken until mid-September to become apparent.

The BSE SENSEX and the Nifty 50 (NSE: NIFTY) indices have plunged from highs in August, and many brows have been knitted in anticipation of a solution. The IL&FS crisis is only the icing on the cake, really, in the broader context of a nationwide pandemic of bad debt that has caused Reserve Bank of India to force corrective framework on 11 of the 21 government-owned banks in recent months, as well as a falling Rupee (INR:USD).

Related Ticker: IFN

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


IFN in +1.02% Uptrend, rising for three consecutive days on August 12, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IFN advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 31, 2026. You may want to consider a long position or call options on IFN as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 195 cases where IFN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IFN moved out of overbought territory on August 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for IFN turned negative on August 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Industry description

India Fund Inc is a non-diversified closed-end management investment company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others.
View a ticker or compare two or three
IFN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Unknown

Profile
Details
Category
India Equity
Address
345 Park AvenueNew York
Phone
N/A
Web
https://www.abrdnifn.com/
Interact to see
Advertisement
During the week of 9–15 February 2026, major U.S. equity indices finished lower overall, while Tickeron’s trending AI trading bots produced positive returns, particularly in defense and energy—two areas now directly affected by the newly opened war in Iran. With macro risk rising and volatility picking up, this divergence matters: it shows how sector‑focused, rules‑based AI strategies can still find upside when broad index exposure is negative.
MRNA surged approximately +16.07% on March 4, 2026, closing at $57.84, up from the prior session's close of $49.83. The primary catalyst was Moderna's announcement of a landmark settlement in its long-running patent dispute over lipid nanoparticle (LNP) technology used in its mRNA vaccines.
Shares of The Trade Desk (TTD) surged +28.05% on March 5, 2026, reaching $32.23 from a prior close of $25.17. The primary catalyst was CEO Jeff Green's record insider purchase of approximately 6 million shares worth ~$148 million — the largest insider buy in the company's history.
AEO shares are trading at $19.89, down $2.56 or -11.40% from the prior session's close of $22.45. The primary catalyst is deeply disappointing Q1 fiscal 2026 operating income guidance of just $20–$25 million, which badly missed analyst expectations.
CIEN shares plunged 14.25% on March 5, 2026, trading at $294.59 versus the prior session's close of $343.55 — a decline of $48.96 per share. The steep sell-off came despite a strong earnings beat: adjusted EPS of $1.35 crushed the consensus estimate of $1.05 by 28.6%, and revenue of $1.43 billion rose 33% year-over-year.
Shares of Victoria's Secret & Co. (VSCO) tumbled approximately 11.87% in early trading on March 5, falling from a prior close of $60.01 to an intraday price near $52.89, with an intraday low of $51.61. The steep decline came despite a Q4 2025 earnings beat, with adjusted EPS of $2.77 topping the consensus estimate of $2.46 and revenue of $2.27 billion exceeding the expected $2.22 billion.
AMPX shares surged +18.57% in today's session, trading at $14.88 versus the prior close of $12.55. Primary catalyst: Q4 and full-year fiscal 2025 earnings, reported before the open, delivered a decisive beat on both EPS and revenue expectations.
EXPE shares are trading up approximately +9.70% intraday on March 5, 2026, rising from a prior close of $221.25 to around $242.71. March 5 is the stock's ex-dividend date for a newly raised quarterly dividend of $0.48 per share — a 20% increase from the prior payout — signaling strong management confidence in cash generation.
SES shares are down approximately 30% intraday on Thursday, March 5, 2026, trading near $1.19 against the prior session's close of $1.71. The primary catalyst is deeply disappointing 2026 revenue guidance of $30–$35 million — roughly 41% below the Wall Street consensus of $51.67 million.
What if a single trading robot could harvest volatility across semiconductors, oil, and communication technology — simultaneously — while filtering out the noise that burns most active traders? That's exactly what the Semiconductors, Oil & Energy, Communication Tech AI Trading Agent delivers. Over the past 364 days (March 5, 2025 – March 4, 2026), this agent generated a Total Net Profit of $20,641.78 on $500-per-trade sizing — an eye-catching Annualized Return of 68.58%. With 1,534 closed trades, a 61.86% win rate, and a dominant Profit Factor of 3.02
What if an AI trading agent could turn market chaos into a 45.55% annualized return? That's exactly what Tickeron's HUBB, AVGO, ITA, QQQ – AI Trading Agent (4 Tickers, 5min) has delivered across 106 days of live trading — posting $11,605.87 in total net profit from a per-trade allocation of $2,500–$8,250, a 69.59% win rate across 444 closed trades, and a Profit Factor of 2.18.
83.97% Win Rate | 87.10% Annualized Return | $44,879.15 Total Net Profit | Profit Factor: 4.92 | Sharpe Ratio: 1.13
HYMC’s latest sell‑off is part of a broader downtrend that accelerated after the company delayed its PEA, which investors interpreted as an uncertainty event despite no immediate change in reported resources or cash position. Technical indicators such as HYMC breaking above its upper Bollinger Band and then rolling over, along with the Aroon indicator turning down in late February, signaled an elevated risk of a sharp pullback that is now playing out.
DSGR reported quarterly EPS of about 0.18 dollars, badly missing consensus estimates of roughly 0.32–0.33 dollars per share and marking a sharp drop from 0.42 dollars a year ago, which triggered a large negative earnings surprise. Revenue of about 481–482 million dollars came in below expectations near 496 million dollars, and adjusted EBITDA margins compressed to about 7.4% from 9.3% in the prior‑year quarter, highlighting cost and mix pressures.
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.